Macrophage cells play an important role in the initiation and regulation of the immune response. All-trans retinoic acid (ATRA) and its natural and synthetic analogs (retinoids) affect a large number of biological processes. Recently , retinoids have been shown promise in the therapy and prevention of various cancers. However, many interesting questions related to the activities of retinoids remain to be answered: (I) Molecular mechanisms by which retinoids exert their effects; (II) why the clinical uses of retinoids give undesirable side effects of varying severity with a higher frequency of blood system symptoms; (III) little is known for its impacts on macrophage cells etc. We set up this experiment, therefore, to examine the apoptosis of ATRA on macrophage Ana-1 cell line. Apoptosis of the cells was quantitated, after staining cells with propidium iodide (PI), by both accounting nuclear condensation and flow cytometry. When the cells were treated with ATRA at or higher than l μM for more than 24 h, significant amount of the apoptotic cells was observed. Induction of apoptosis of Ana-1 cells by ATRA was in time-and dose-dependent manners, exhibiting the similar pattern as the apoptosis induced by actinomycin D (ACTD). ATRA treatment of Ana-1 cells also caused the changes of the mRNA levels of 
INTRODUCTION
Retinoids possess a broad spectrum of biological activities relevant to various aspects of growth, differentiation, morphogenesis and development, and immune response [1] . In clinical aspects, retinoids have been tested extensively in cancer therapy and prevention [2, 3] . The most successful case so far has been to use all-trans retinoic acid (ATRA) in treatment of patients with acute promyelocytic leukemia [4] [5] [6] [7] . However, the molecular mechanisms underlying the effects of retinoids are not fully understood yet.
Many therapeutic reagents have been reported to exert their anti-cancer effects through induction of cell apoptosis, the programmed cell death [8] [9] [10] [11] [12] . Recent studies have also shown that retinoids can induce apoptosis in some cancer cells [3, 6] , as well as human B lymphocytes [5] . Induction of cell apoptosis by retinoids is considered to be related to change of expression of bcl-2 gene, an important regulator in apoptosis [6] . There is no report yet in the aspect of its apoptotic effect on macrophage cells, which plays crucial immunological functions. In this report, we demonstrated, using Ana-1 cells as a model system, ATRA indeed induced apoptosis of macrophage in time-and dose-dependent manners. Treatment of Ana-1 cells with ATRA were also associated with the change in the expression of apoptosis-associated gene bcl-2.
MATERIALS AND METHODS

Cell cultures and drug treatment
Macrophage Ana-1 cells were kindly provided by professor Z. L. Zhang, and grown in RPMI 1640 (GIBCO) supplemented with 10% heat-inactivated fetal calf serum (Evergreen), 100 U / ml penicillin, 100μg / ml streptomycin and 2 mM glutamine. Exponentially growing Ana-1 cells (5×10 
Morphological analysis of apoptotic cells
Random fields of each treated cultures were photographed through a 40× objective lens in both the phase and the fluorescent modes. Apoptotic cells, after staining with propidium iodide (PI, Sigma), were much smaller than the viable cells and presented a condensed chromatin and fragmented nuclear chromatin bodies [13] [14] [15] . The percentage of apoptotic cells was calculated by counting at least 500 cells. Independent experiments were carried out for at least three times, and the data were given as the mean ± SEM.
Apoptotic analysis by flow cytometry ATRA-treated and untreated Ana-1 cells 2×10 6 were washed twice with phosphate buffered saline (PBS) containing 0.1% glucose and then fixed in 1 ml ice-cold ethanol overnight at 4℃. The fixed cells were pelleted and resuspended in 0.5 ml of PBS containing 0.1% glucose, 30μg / ml PI, and 1 mg / ml RNase A (Sigma). The DNA contents of the cell were analyzed by flow cytometry (Becton-Dickinson, San Jose. CA) as described [16, 17] .
Northern blot analysis
Extraction of total RNA and Northern blots were performed as described [18] . Blots were then hybridized to a DNA probe of human bcl-2 gene with the EcoRI/Hind III insert from plasmid PFL1 [19] , which was radiolabeled with α-32 p-dATP (Amersham) using random primering to a specific activity of 1-2 × 10 9 cpm/μg DNA. Blots were exposed to X-ray films (Kodak) for three to
Statistical analysis X 2 tests were used. Statistical significance was defined by P<0.05.
RESULTS
Morphological changes induced by ATRA consistent with apoptosis
The effects of ATRA on the morphology of Ana-1 cells were tested using the fluorescent staining of nuclear DNA with PI. Treatment of Ana-1 cells with 10 μM ATRA for 48 h (Fig 1) resulted in morphological changes characteristic of apoptosis, including condensation of chromatin at the nuclear membrane and nuclear fragmentation with groups of isolated pieces of condensed chromatin. Similar morphology of apoptosis was observed for the cells treated with 1 μM ACTD (data not shown).
Time-and dose-dependent manners of ATRA-induced apoptosis
Quantitation of apoptosis was determined in Ana-1 cells by counting at least 500 cells, and apoptotic cells are expressed in Fig 2 as percent of total Ana-1 cells counted with the mean ± SEM. Counting cells at different intervals showed that no enhancement of apoptosis was detected at 12 h (data not shown) but significant apoptosis (P<0.01) could be observed at 24 h and reached the maximal level after 48 h of incubation with 10 μM ATRA, similar to that with 1 μM ACTD. ATRA at 1 μM was less effective in inducing apoptosis (Fig 2) and ATRA at 100 nM did not prompt apoptosis in Ana-1 cells (data not shown). AT R A -t r e a t e d c e l l s ( b ) , 1 0μM AT R A -t r e a t e d c e l l s ( c ) , a n d 1μM ACTD-treated cells (d). X 2 analysis showed the drug-induced apoptosis as measured by the area under sub-G1 peak in the histograms were significant higher than that in the control (P<0.01 for 1 μM ATRA, P<0.001 for 10μM ATRA or 1μM ACTD). X-axis represents fluorescence intensity and Y-axis stands for relative cell numbers.
ATRA-induced Changes of the mRNA levels of apoptosis-associated gene bcl-2
Expression of apoptosis-associated gene bcl-2 was detected by Northern blot analysis in drug-untreated Ana-1 cells as shown in Fig 4. After 24 h of ATRA treatment of the cells at both 1 and 10 μM , the bcl-2 expression decreased. The mRNA levels of bcl-2 gene were higher than that of the control after 48 h but then almost totally diminished after 72 h of ATRA incubation. The temporal pattern of changes of bcl-2 mRNA levels after ATRA treatment was resembling to that after ACTD treatment. Two independent experiments gave similar results.
DISCUSSION
It has been known that retinoids can induce cell differentiation, which has been considered as one of the molecular mechanisms underlying the use of retinoids in cancer therapy [2] . A recent report has shown that retinoids promote apoptosis in human B lymphocyte cells [5] , we designed to study if retinoids could induce apoptosis of macrophage cells.
The most direct method of detecting and quantifying apoptosis in cell cultures is to examine the morphology of cells after stained with fluorescent dyes such as PI [20] . A flow cytometry method based on a reduction in DNA staining and cell shrinkage has been also widely used for detection of apoptosis [21] . Both methods have been used in this study to detect apoptotic effect of ATRA in macrophage Ana-1 cells, and the results from both methods agreed well with each other.
With typical characteristics of apoptosis in Ana-1 cells after ATRA treatment as shown in Fig 1, combination of Fig 2 and 3 further confirmed that ATRA indeed prompts apoptosis in macrophage cells. Our results also indicated the time-and dose-dependent manners of the ATRA's action. Generally, it requires about 1 μM ATRA and more than 12 h for the drug to induce apoptosis in Ana-1 cells. The apparent pattern of the effect of ATRA on apoptosis was resembling to that of ACTD, though the molecular mechanisms for the apoptotic effects of those two reagents may be different. It has been shown that a series of genes are involved in regulation of apoptosis, and bcl-2 is one of the most relevant among them [6, 9, 10, 12, 18, 22] . Our study revealed that stimulation of Ana-1 cells with the retinoid could change the mRNA levels of bcl-2 gene. However, ATRA-induced changes of bcl-2 expression are in a complicated way: after initial decreasing at 24 h, the levels of bcl-2 mRNA increased at 48 h and then almost totally diminished at 72 h of ATRA treatment. The ACTD incubation gave the qualitatively similar pattern of changes of bcl-2 expression. The results were reproducible in two independent experiments. We don't have a reasonable explanation, at the moment, for this phenomenon. It could be speculated that several parallel pathways may be involved in the regulation of apoptosis in macrophage Ana-1 cells, as depicted in other types of cells [23] [24] [25] [26] [27] [28] [29] , and the interactions of these apoptotic pathways result in the complicated pattern of bcl-2 expression. Our results, anyway, clearly show that retinoid can induce the changes of bcl-2 expression. It remains to further examine if retinoids could induce the regulations of other apoptosis-related genes such as p53 in macrophage cells.
